Home Monitoring of Cardiac Devices in the Era of COVID-19

Miller, Jennifer C.; Skoll, Devin; Saxon, Leslie A.

doi:10.1007/s11886-020-01431-w

Cited by 43 publications

(28 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nevertheless, with the increased adoption of RPM, there needs to be greater data transparency, better protocols for the safe implementation of RPM and more user-friendly systems [ 90 ]. Further hardware refinements are also needed to address some of the current challenges faced with the use of wearables for RPM that relate to long-term application (e.g., patches), skin-device interface and energy autonomy [ 91 ].…”

Section: Wearables To Assist In Transition Of Medical Management Fmentioning

confidence: 99%

Smart Wearables for Cardiac Monitoring—Real-World Use beyond Atrial Fibrillation

Duncker

Ding

Etheridge

et al. 2021

Sensors

View full text Add to dashboard Cite

The possibilities and implementation of wearable cardiac monitoring beyond atrial fibrillation are increasing continuously. This review focuses on the real-world use and evolution of these devices for other arrhythmias, cardiovascular diseases and some of their risk factors beyond atrial fibrillation. The management of nonatrial fibrillation arrhythmias represents a broad field of wearable technologies in cardiology using Holter, event recorder, electrocardiogram (ECG) patches, wristbands and textiles. Implementation in other patient cohorts, such as ST-elevation myocardial infarction (STEMI), heart failure or sleep apnea, is feasible and expanding. In addition to appropriate accuracy, clinical studies must address the validation of clinical pathways including the appropriate device and clinical decisions resulting from the surrogate assessed.

show abstract

Section: Wearables To Assist In Transition Of Medical Management Fmentioning

confidence: 99%

Smart Wearables for Cardiac Monitoring—Real-World Use beyond Atrial Fibrillation

Duncker

Ding

Etheridge

et al. 2021

Sensors

View full text Add to dashboard Cite

show abstract

“…Moreover, the pandemic has led to a worldwide implementation of remote monitoring of cardiac implantable electronic devices, in order to reduce the in‐office device control and reduce the risk of contagion. 86 , 87 …”

Section: Role Of E‐cardiology In the Evaluation And Management Of Chronic Coronavirus Disease 2019‐linked Clinical Manifestationsmentioning

confidence: 99%

“…Moreover, the pandemic has led to a worldwide implementation of remote monitoring of cardiac implantable electronic devices, in order to reduce the in-office device control and reduce the risk of contagion. 86,87 Post COVID-19 in general cardiology Another e-cardiology approach represents telemonitoring with a daily transfer of vital parameter. This remote patient management model was established for recently hospitalized high-risk HF patients and is very beneficial under current pandemic conditions to these patients who are also at high risk for COVID-19.…”

Section: Role Of E-cardiology In the Evaluation And Management Of Chronic Coronavirus Disease 2019-linked Clinical Manifestationsmentioning

confidence: 99%

Late phase of COVID‐19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice

et al. 2021

View full text Add to dashboard Cite

Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID‐19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID‐19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infection, and a ‘long COVID‐19’ illness has been recognized with fatigue, chest pain, and dyspnoea among the most frequent symptoms reported after discharge from hospital. This paper focuses on some open questions that cardiologists are going to face during the next months in a general cardiology outpatient clinic, in particular how to evaluate a ‘post‐COVID’ patient during follow‐up of CV complications of the acute phase and how to manage new CV symptoms that could be the consequence, at least in part, of heart/vessels and/or lung involvement of the previous virus infection. Present symptoms and signs, history of previous CV disease (both preceding COVID‐19 and occurring during viral infection), and specific laboratory and imaging measurements during the acute phase may be of interest in focusing on how to approach the clinical evaluation of a post‐COVID patient and how to integrate in our standard of care the new information on COVID‐19, possibly in a multidisciplinary view. Dealing with the increased COVID‐associated CV risk burden and becoming acquainted with potential new e‐cardiology approaches aimed at integrating the cardiology practice are relevant new challenges brought by severe acute respiratory syndrome coronavirus 2 infection and its sequelae.

show abstract

“…et al [ 22 ] had mentioned the importance of telemedicine on the cardiac rehabilitation patients in the period of coronavirus. Miller J.C. et al [ 23 ] had surveyed the relevance of the smart devices used by the remote cardiac patients in this global pandemic crisis. Moreover, such patients were monitored through Remote Patient Monitoring (RPM) from their homes/quarantines from the heart perspectives.…”

Section: Related Workmentioning

confidence: 99%

Cryptographic Engineering on COVID-19 Telemedicine: An Intelligent Transmission Through Recurrent Relation Based Session Key

Dey¹,

Bhowmik²,

Sarkar³

et al. 2021

Wireless Pers Commun

View full text Add to dashboard Cite

Constraints imposed due to the cameo of the novel corona virus has abruptly changed the operative mode of medical sciences. Most of the hospitals have migrated towards the telemedicine mode of services for the non-invasive and non-emergency patients during the COVID-19 time. The advent of telemedicine services has remotely rendered health services to different types of patients from their isolates. Here, the patients’ medical data has to be transmitted to different physicians/doctors in a safe manner. Such data are to be secured with a view to restore its privacy clause. Cardio vascular diseases (CVDs) are a kind of cardiac disease related to blockage of arteries and veins. Cardiac patients are more susceptible to the COVID-19 attacks. They are advised to be treated though cardiac telemedicine services. This paper presents an intelligent and secured transmission of clinical cardiac reports of the patients through recurrence relation based session key. Such reports were made through the following confusion matrix operations. The beauty of this technique is that confusion matrices are transferred to specified number of cardiologists with additional secret shares encapsulation. The case of robustness checking, transparency and cryptographic engineering has been tested under different set of inputs. The total cryptographic time observed here was noted as ms, 3 ms , ms, ms, ms, and 660.16 ms, which is acceptable when compared with other classical techniques. The estimation of correlation coefficient in proposed variables has been recorded as − . Different types of result and its analysis proves the efficiency of the proposed technique. It will provide more security in medical data transmission, especially in the needy hours of COVID-19 pandemic.

show abstract

Home Monitoring of Cardiac Devices in the Era of COVID-19

Cited by 43 publications

References 61 publications

Smart Wearables for Cardiac Monitoring—Real-World Use beyond Atrial Fibrillation

Smart Wearables for Cardiac Monitoring—Real-World Use beyond Atrial Fibrillation

Late phase of COVID‐19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice

Cryptographic Engineering on COVID-19 Telemedicine: An Intelligent Transmission Through Recurrent Relation Based Session Key

Contact Info

Product

Resources

About